NAGAWA is a pharmaceutical manufacturer and distributor that obtained the license for manufacturing and sales of Class I/II drugs in June 2019. Our mission is to provide high-quality and effective Japanese medicines to patients, including children, with limited access to medical care in Southeast Asia, including China. Additionally, we strive to meet the unmet needs of domestic sales.